Skip to content

Clinical trials

Phase 4 Myocardial Infarction trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 4 Country / region: Russia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20131
20141
20171
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Penza State University2
Eli Lilly and Company1
Istituto Auxologico Italiano1
KU Leuven1
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction6
ST Elevation Myocardial Infarction3
Dementia1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Heart Failure1
Hypertension1
Ischemic Attack, Transient1
Non-ST Elevated Myocardial Infarction1
Stroke1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.